$281 Million is the total value of Canaan Partners XI LLC's 6 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DAWN | DAY ONE BIOPHARHACEUTICALS I | $172,979,000 | +80.4% | 9,663,645 | 0.0% | 61.60% | +54.3% | |
| AEVA | AEVA TECHNOLOGIES INC | $57,859,000 | -27.6% | 18,485,197 | 0.0% | 20.61% | -38.1% | |
| TYRA BIOSCIENCES INC | $31,531,000 | -33.2% | 4,409,991 | 0.0% | 11.23% | -42.8% | ||
| RALLYBIO CORP | $18,193,000 | +8.2% | 2,409,712 | 0.0% | 6.48% | -7.5% | ||
| VECT | VECTIVBIO HLDG AG | $200,000 | +14.3% | 37,051 | 0.0% | 0.07% | -2.7% | |
| BIRD GLOBAL INC | $30,000 | -82.2% | 69,270 | 0.0% | 0.01% | -84.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DAY ONE BIOPHARMACEUTICALS I | 8 | Q3 2023 | 61.6% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 53.3% |
| AEVA TECHNOLOGIES INC | 8 | Q3 2023 | 36.0% |
| RALLYBIO CORP | 8 | Q3 2023 | 14.1% |
| VECTIVBIO HLDG AG | 7 | Q2 2023 | 0.3% |
| BIRD GLOBAL INC | 5 | Q4 2022 | 0.1% |
| MONEYLION INC | 1 | Q3 2023 | 1.4% |
| MONEYLION INC | 1 | Q2 2023 | 0.6% |
View Canaan Partners XI LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-05 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2023-10-11 |
| 13F-HR | 2023-07-13 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-10-31 |
| 4 | 2022-09-22 |
| 4 | 2022-09-20 |
| 4 | 2022-09-15 |
View Canaan Partners XI LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.